Clinical trials: Randomized 1:1 to Received TN Plus WBR or Only WBR
Phase II Clinical Trial, Ninety-six Histologically Confirmed NSCLC Patients With BM
Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients
Background: Whole-brain radiotherapy (WBRT) is the standard treatment for multiple brain metastases (BM), in NSCLC patients who are not candidates for treatment with stereotactic radiation body therapy.
- Conditions
- Phase II Clinical Trial, Ninety-six Histologically Confirmed NSCLC Patients With BM, Randomized 1:1 to Received TN Plus WBR or Only WBR, ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI
- Trial name
- NCT04338867
- Testing
- Whole-brain radiotherapy
- Where
- Mexico
- Volunteers
- 96 people
- Sponsor
- Instituto Nacional de Cancerologia de Mexico